Education
About Us
Working with TipRanks
Follow Us
Genix Pharmaceuticals Corporation (TSE:GENX)
:GENX
GENX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.03 - C$0.09
Previous CloseN/A
VolumeN/A
Average Volume (3M)900.00
Market Cap
C$2.07M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)739.34K
Price to Earnings (P/E)―
Beta0.46
Next Earnings
Sep 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding59,224,133
10 Day Avg. Volume1,100
30 Day Avg. Volume900
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Genix Pharmaceuticals News
PremiumCompany Announcements
Genix Pharmaceuticals Reports 2025 Shareholder Meeting Outcomes
PremiumCompany Announcements
Genix Pharmaceuticals Enhances Warrant TermsOptions Prices
Currently, No data available
---
Ownership Overview
1.50% Insiders
―
Mutual Funds
― Other Institutional Investors
98.50% Public Companies and
Individual Investors
GENX FAQ
What was Genix Pharmaceuticals Corporation’s price range in the past 12 months?
Genix Pharmaceuticals Corporation lowest stock price was C$0.03 and its highest was C$0.09 in the past 12 months.
What is Genix Pharmaceuticals Corporation’s market cap?
Genix Pharmaceuticals Corporation’s market cap is C$2.07M.
When is Genix Pharmaceuticals Corporation’s upcoming earnings report date?
Genix Pharmaceuticals Corporation’s upcoming earnings report date is Sep 25, 2025 which is in 89 days.
How were Genix Pharmaceuticals Corporation’s earnings last quarter?
Genix Pharmaceuticals Corporation released its earnings results on Jun 18, 2025. The company reported -C$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.001.
Is Genix Pharmaceuticals Corporation overvalued?
According to Wall Street analysts Genix Pharmaceuticals Corporation’s price is currently Overvalued.
Does Genix Pharmaceuticals Corporation pay dividends?
Genix Pharmaceuticals Corporation does not currently pay dividends.
What is Genix Pharmaceuticals Corporation’s EPS estimate?
Genix Pharmaceuticals Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genix Pharmaceuticals Corporation have?
Genix Pharmaceuticals Corporation has 59,224,133 shares outstanding.
What happened to Genix Pharmaceuticals Corporation’s price movement after its last earnings report?
Genix Pharmaceuticals Corporation reported an EPS of -C$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Genix Pharmaceuticals Corporation?
Currently, no hedge funds are holding shares in TSE:GENX
Company Description
Genix Pharmaceuticals Corporation
Genix Pharmaceuticals Corp is a Canadian life sciences company engaged in the research, development, manufacturing and marketing of high growth, high margin, novel and proprietary, evidence-based, pharmaceuticals, over-the-counter products, nutraceuticals and healthcare products, as well as generic medicines.
Technical Analysis
Alchemist Mining
―
NeutriSci International
―
Lifeist Wellness
―
Hash Corporation
―
Hempshire Group Inc
―